Dual-targeting the Dynorphin/kappa Opioid Receptor and Dopamine Systems for Treatment of Cocaine Use Disorder
Year: 2021
Type: dissertation
Abstract: Decades of research have focused on discovering an effective pharmacotherapy for cocaine use disorder, and despite hundreds of clinical trials testing a wide range of cellular targets, there is still no FDA approved treatment for cocaine addiction. The work contained in this dissertation focuses on the dysregulation of the dopamine and dynorphin/kappa opioid receptor systems that occurs after repeated, high-dose cocaine exposure. These system changes result in a reward deficit, stress surfeit syndrome seen during withdrawal, which leads to greater drug intake and increases the propensity to relapse. The aim of this research was assessing the functional state of the kappa opioid receptor system after cocaine self-administration and the benefits of targeting this system—and its interactions with the dopamine system—to decrease cocaine self-administration and reverse neurobiological alterations resulting from cocaine exposure.
Author: Estave, Paige
Institution: Wake Forest University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: G2776647444, Reversing Cocaine-induced Neurobehavioral Deficits using a Combination Drug Approach, Center for the Neurobiology of Addiction Treatment, Ethanol Dependence Induced Changes in Dopamine Signaling in Basolateral Amygdala, Animal Models of Cocaine Addiction, RGS2 regulation of D2 receptor signaling, The Neurobiology of Drug Abuse, Multidisciplinary Training in the Biology of Alcohol Addiction, Alcohol/Stress Effects on Kappa Opioid Receptors in the Amygdala and Accumbens
OpenAlex ID: W7037261305
